Found 0 matching trials
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
PHASE3The purpose of this trial is to evaluate AMG 162 in the treatment of bone l...
Location
Multiple Locations
RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis
PHASE4The objective of this study was to conduct a randomized, double-blind, doub...
Location
The Chinese University of Hong Kong
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
PHASE3This study will evaluate the effectiveness and safety of denosumab in treat...
Location
Multiple Locations
Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis
PHASE3To evaluate the effect of denosumab on lumbar spine bone mineral density (B...
Location
Childrens Hospital of Los Angeles
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
PHASE3The purpose of this study is to determine if denosumab is non-inferior to z...
Location
Multiple Locations
China HVT Safety, PK, PD
PHASE1This study is to evaluate the safety, tolerability, pharmacokinetics, and p...
Location
GSK Investigational Site
RANKL Inhibition and Mammographic Breast Density
PHASE2Data supporting a role for RANKL signaling in mammographic density and brea...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Denosumab in Primary Hyperparathyroidism
PHASE4Primary hyperparathyroidism (PHPT), a disease characterized by excess parat...
Location
Columbia University Medical Center
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
PHASE3This is a phase 3, randomized, double-blind, placebo-controlled study to ev...
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
PHASE2Aortic stenosis is a condition whereby one of the heart valves (aortic valv...
Location
Clinical Research Facility University of Edinburgh